Efficacy of the Targeted Triple Therapy With Giltertinib, Venetoclax, and Azacitidine as a Bridge to Allogenic Hematopoietic Stem Cell Transplant in Relapsed Refractory FLT3㏄ositive Acute Myeloid Leukemia in Children

发表于 2026-7-25 10:16:52

期刊：Pediatric Blood & Cancer

文献作者：Yamini Krishnan; Smitha Bhaskaran; Gazel Sainulabdin; Krishnan Vettakorumakankavu Parameswaran

出版日期：--

DOI号：10.1002/1545-5017.70427

下载链接：https://onlinelibrary.wiley.com/ ... 002/1545-5017.70427

文献链接：https://doi.org/10.1002/1545-5017.70427

当前文献来源于 Wiley。

备注信息：

发表于 2026-7-25 10:16:53

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Wiley] Efficacy of the Targeted Triple Therapy With Giltertinib, Venetoclax, and Azacitidine as a Bridge to Allogenic Hematopoietic Stem Cell Transplant in Relapsed Refractory FLT3㏄ositive Acute Myeloid Leukemia in Children

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Wiley] Efficacy of the Targeted Triple Therapy With Giltertinib, Venetoclax, and Azacitidine as a Bridge to Allogenic Hematopoietic Stem Cell Transplant in Relapsed Refractory FLT3㏄ositive Acute Myeloid Leukemia in Children 一键复制